Efficacy of a general practitioner training campaign for early detection of melanoma in France

British Journal of Dermatology

Volumn 170, Issue 1, 2014, Pages 123-129

  Grange, F ^a   Woronoff, A S ^b   Bera, R ^a   Colomb, M ^a   Lavole, B ^c   Fournier, E ^b   Arnold, F ^d   Barbe, C ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

^c Réseau de Cancérologie de Champagne Ardenne   (France)

^d Association Departementale des Professions de Sante Pour le Depistage des Cancers   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AWARENESS; BRESLOW THICKNESS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER PREVENTION; CARCINOMA IN SITU; CONTROLLED STUDY; DEMOGRAPHY; DERMATOLOGIST; EARLY DIAGNOSIS; EVALUATION STUDY; FRANCE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; MELANOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGRAM EFFECTIVENESS; SECONDARY PREVENTION; SKINFOLD THICKNESS; TUMOR INVASION; DERMATOLOGY; EDUCATION; HEALTH PERSONNEL ATTITUDE; PILOT STUDY; PROCEDURES; PSYCHOLOGY; SATISFACTION; SKIN NEOPLASMS; STANDARDS;

ATTITUDE OF HEALTH PERSONNEL; DERMATOLOGY; EARLY DETECTION OF CANCER; EDUCATION, MEDICAL, CONTINUING; FRANCE; GENERAL PRACTICE; GENERAL PRACTITIONERS; HUMANS; MELANOMA; PERSONAL SATISFACTION; PILOT PROJECTS; SKIN NEOPLASMS;

EID: 84891107252     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12585     Document Type: Article

References (38)

1. Grange F,. Epidemiology of cutaneous melanoma: descriptive data in France and Europe. Ann Dermatol Venereol 2005; 132: 975-82 (in French).
2. MacKie RM, Hole D, Hunter JA, et al,. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish melanoma group. BMJ 1997; 315: 1117-21.
3. Ferlay J, Parkin DM, Steliarova-Foucher E,. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46: 765-81.
4. Garbe C, Leiter U,. Melanoma epidemiology and trends. Clin Dermatol 2009; 27: 3-9.
5. Hodi FS, O'Day SJ, McDermott DF, et al,. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711-23.
6. Chapman PB, Hauschild A, Robert C, et al,. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364: 2507-16.
7. Robert C, Thomas L, Bondarenko I, et al,. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med 2011; 364: 2517-26.
8. Flaherty KT, Robert C, Hersey P, et al,. Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med 2012; 367: 107-14.
9. Topalian SL, Hodi FS, Brahmer JR, et al,. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012; 366: 2443-54.
10. Geller AC, Swetter SM, Oliveria S, et al,. Reducing mortality in individuals at high risk for advanced melanoma through education and screening. J Am Acad Dermatol 2011; 65 (5 Suppl. 1): S87-94.
11. Wolff TT, Tai EE, Miller TT,. Screening for Skin Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force. Rockville, MD: U.S. Agency for Healthcare Research and Quality, 2009.
12. Durbec F, Vitry F, Granel-Brocard F,. et al. The role of circumstances of diagnosis and access to dermatological care in early diagnosis of cutaneous melanoma: a population-based study in France. Arch Dermatol 2010; 146: 240-6.
13. Breitbart EW, Waldmann A, Nolte S, et al,. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol 2012; 66: 201-11.
14. Geller AC, Greinert R, Sinclair C, et al,. A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the international task force on skin cancer screening and prevention (September 24 and 25, 2009). Cancer Epidemiol 2010; 34: 355-8.
15. Grange F, Hédelin G, Halna J-M, et al,. Assessment of a general practitioner training campaign for early detection of cutaneous melanoma in the Haut-Rhin department of France. Ann Dermatol Venereol 2005; 132: 956-61.
16. Grange F, Barbe C, Mas L, et al,. The role of general practitioners in diagnosis of cutaneous melanoma: a population-based study in France. Br J Dermatol 2012; 167: 1351-9.
17. Grange F, Barbe C, Aubin F, et al,. Clinical and sociodemographic characteristics associated with thick melanomas: a population-based, case-case study in France. Arch Dermatol 2012; 148: 1370-6.
18. Saiag P,. Toward a new place for dermatologists in the diagnosis of melanoma in France? Br J Dermatol 2012; 167: 1199.
19. Barbe C, Hibon E, Vitry F, et al,. Clinical and pathological characteristics of melanoma: a population-based study in a French regional population. J Eur Acad Dermatol Venereol 2012; 26: 159-64.
20. Grob JJ, Richard MA, Gouvernet J, et al,. The kinetics of the visible growth of a primary melanoma reflects the tumor aggressiveness and is an independent prognostic marker: a prospective study. Int J Cancer 2002; 102: 34-8.
21. Liu W, Dowling JP, Murray WK, et al,. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch Dermatol 2006; 142: 1551-8.
22. Mandalà M, Imberti GL, Piazzalunga D, et al,. Association of socioeconomic status with Breslow thickness and disease-free and overall survival in stage I-II primary cutaneous melanoma. Mayo Clin Proc 2011; 86: 113-19.
23. Smith T,. The Queensland Melanoma project-an exercise in health education. Br Med J 1979; 1: 253-4.
24. Doherty VR, MacKie RM,. Experience of a public education programme on early detection of cutaneous malignant melanoma. BMJ 1988; 297: 388-91.
25. MacKie RM, Hole D,. Audit of public education campaign to encourage earlier detection of malignant melanoma. BMJ 1992; 304: 1012-15.
26. Melia J, Cooper EJ, Frost T, et al,. Cancer research campaign health education programme to promote the early detection of cutaneous malignant melanoma. II. Characteristics and incidence of melanoma. Br J Dermatol 1995; 132: 414-21.
27. Herd RM, Cooper EJ, Hunter JA, et al,. Cutaneous malignant melanoma. Publicity, screening clinics and survival-the Edinburgh experience 1982-90. Br J Dermatol 1995; 132: 563-70.
28. Cristofolini M, Bianchi R, Boi S,. et al. Analysis of the cost-effectiveness ratio of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy. Cancer 1993; 71: 370-4.
29. Melia J, Moss S, Coleman D, et al,. The relation between mortality from malignant melanoma and early detection in the cancer research campaign mole watcher study. Br J Cancer 2001; 85: 803-7.
30. Criscione VD, Weinstock MA,. Melanoma thickness trends in the United States, 1988-2006. J Invest Dermatol 2010; 130: 793-7.
31. Katalinic A, Waldmann A, Weinstock MA, et al,. Does skin cancer screening save lives? An observational study comparing trends in melanoma mortality in regions with and without screening. Cancer 2012; 118: 5395-402.
32. Richard MA, Grob JJ, Avril MF, et al. Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer 2000; 89: 280-5.
33. Pennie ML, Soon SL, Risser JB, et al. Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist. Arch Dermatol 2007; 143: 488-94.
34. Terushkin V, Halpern AC,. Melanoma early detection. Hematol Oncol Clin North Am 2009; 23: 481-500, viii.
35. Marashi-Pour S, Morrell S, Cooke-Yarborough C, et al. Competing risk analysis of mortality from invasive cutaneous melanoma in New South Wales: a population-based study, 1988-2007. Aust N Z J Public Health 2012; 36: 441-5.
36. Van der Rhee HJ, Van der Spek-Keijser LM, Van Westering R, Coebergh JW,. Increase in and stabilization of incidence and mortality of primary cutaneous malignant melanoma in Western Netherlands, 1980-95. Br J Dermatol 1999; 140: 463-7.
37. Lipsker DM, Hedelin G, Heid E, et al. Striking increase of thin melanomas contrasts with stable incidence of thick melanomas. Arch Dermatol 1999; 135: 1451-6.
38. Lipsker D, Engel F, Cribier B, et al. Trends in melanoma epidemiology suggest three different types of melanoma. Br J Dermatol 2007; 157: 338-43.